Updates in Renal Disease — Evaluation and Management of Chronic Kidney Disease

Pharmacotherapy Specialists, particularly those working with patients with renal disease, must be able to evaluate current literature and guidelines to adequately treat patients. The Updates in Renal Disease—Evaluation and Management of Chronic Kidney Disease (CKD) will focus on the evolution of kidney function assessment equations and differences between evaluation methods, the role of pharmacologic agents in reducing chronic kidney disease progression, and the application of medication decision-making. This learning activity is designed to advance the participants' knowledge and skills concerning the management of renal disease. Knowing how to apply kidney-function equations to determine the severity of CKID and identifying safe and effective treatment is critical. Pharmacists who can use this knowledge to design patient-specific treatment plans to enhance or preserve kidney function can positively impact the outcomes of CKD patients. This presentation allows participants to critically evaluate such scientific evidence surrounding CKD and effectively incorporate the activities taught into their daily practice.

Updates in Cardiac Disease — Evaluation and Management of Heart Failure

Understanding the classifications and stages of heart failure will help Pharmacotherapy Specialists better understand disease severity and determine the approach to treatment. Evaluations and Management of Heart Failure will explore cutting-edge, contemporary therapeutic topics and demonstrate scientifically sound clinical reasoning and decision-making in the field. Because pharmacists are responsible for developing appropriate and effective patient-specific treatment plans, early identification of potential challenges or complications caused by introducing new medications is a crucial skill. This presentation will focus on the classifications and stages of heart failure, medications used to treat and avoid in treating heart failure, evaluate clinical practice guidelines, and develop evidence-based treatment regimens. The learning activity is designed to advance the participants' skills and ability to critically evaluate the scientific evidence behind cardiac-specific drug therapies and their role in disease progression and patient care.

This presentation has been created by Dr. Ashley Schenk and is being presented by Dr. Sara Brouse at the ACCP 2023 Annual Meeting.